<DOC>
	<DOCNO>NCT03001518</DOCNO>
	<brief_summary>The goal pilot study evaluate describe immunologic overall outcomes subject undergo routine pancreatectomy without irreversible electroporation ( IRE ) pancreatic cancer . Immunologic marker blood measure several time point surgery determine surgical approach associate different immunologic response . Secondary outcome include mortality morbidity ; operative time ; blood loss transfusion requirement ; oncologic outcome : margin status , lymph node harvest , disease-free survival , overall survival . Analysis immune response help investigator determine whether expand pilot large study .</brief_summary>
	<brief_title>Immunologic Signatures Following Surgery Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Subject must least 18 year age least minimum age majority accord applicable State Country Law . Subject suitable surgical candidate , i.e. , able undergo general anesthesia pancreatectomy diagnosis cancer Subject willing able undergo additional blood draw â€¢ Subject suitable candidate surgery , surgery unable complete</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>